1. Mast cells and the gut-liver Axis: Implications for liver disease progression and therapy
    Bhagyalakshmi Nair et al, 2024, Life Sciences CrossRef
  2. Histamine H3 Receptor Signaling Regulates the NLRP3 Inflammasome Activation in C2C12 Myocyte During Myogenic Differentiation
    Yan Chen et al, 2021, Frontiers in Pharmacology CrossRef

  3. Histamine H3 Receptor Promotes Cell Survival via Regulating PKA/CREB/CDKN1A Signal Pathway in Hepatocellular Carcinoma


    Chunle Zhang et al, 2020, OncoTargets and Therapy CrossRef
  4. A high-throughput screen identifies inhibitors of lung cancer stem cells
    Xiaofei She et al, 2021, Biomedicine & Pharmacotherapy CrossRef
  5. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer
    Yuanyi Yue et al, 2022, Frontiers in Immunology CrossRef
  6. Current and novel approaches in the pharmacological treatment of hepatocellular carcinoma
    Fernanda Villarruel-Melquiades et al, 2023, World Journal of Gastroenterology CrossRef
  7. Immune microenvironment in hepatocellular carcinoma: current concepts and the role of blockade of immune checkpoints
    E.L. Bueverova et al, 2024, Molekulyarnaya Meditsina (Molecular medicine) CrossRef
  8. Construction of a Prognostic Risk Prediction Model for Obesity Combined With Breast Cancer
    Na Sun et al, 2021, Frontiers in Endocrinology CrossRef
  9. Cardioprotective effects of H3 receptor activation could be double-sided: insights from isoproterenol-induced cardiac injury
    H. Fehmi Özel et al, 2024, Pflügers Archiv - European Journal of Physiology CrossRef
  10. Exploring the role of mast cells in the progression of liver disease
    Shizhuan Huang et al, 2022, Frontiers in Physiology CrossRef